Evidence map›Paper›PMID 37338507›Full record

ArticleAging2023

Advances in cancer therapy: clinical benefit of new cancer drugs.

Daniel Tobias Michaeli, Julia Caroline Michaeli, Thomas Michaeli

Abstract readEditorial
In one paragraph

Article in Aging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Clinical and geriatric factors associated with fracture risk in older adults with bone metastases: A prospective observational study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Advance care planning for adults with cancer.The Cochrane database of systematic reviews · 2025
    Article
  8. Article
  9. Article
  10. Experiences and Comfort of Young Cancer Patients Discussing Cannabis with Their Providers: Insights from a Survey at an NCI-Designated Cancer Center.Journal of cancer education : the official journal of the American Association for Cancer Education · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Daniel Tobias MichaeliDepartment of Personalized Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.
Julia Caroline MichaeliDepartment of Obstetrics and Gynaecology, LMU University Hospital, LMU Munich, Germany.
Thomas MichaeliDepartment of Personalized Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsNeoplasmsHumansAntineoplastic Agentscancer drugclinical benefitclinical trialoverall survivalprogression-free survival

Identifiers

PMID37338507
PMCPMC10333065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.